Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damian J Green

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Current Hematologic Malignancy Reports|February 2, 2017
A View from the Plateau: Is There a Role for Allogeneic Stem Cell Transplantation in the Era of Highly Effective Therapies for Multiple Myeloma?Damian J Green, William I Bensinger
British Journal of Haematology|November 28, 2023
Unveiling the link between genetic alterations in gamma secretase and BCMA surface density in multiple myelomaAndrew J Cowan, Damian J Green
Cancer Research|April 22, 2017
Whither Radioimmunotherapy: To Be or Not To Be?Damian J Green, Oliver W Press
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T Cells for Multiple Myeloma: The Journey So Far-And the Road AheadAndrew J Cowan, Sherilyn A Tuazon, Andrew J Portuguese, et al.
EJNMMI Radiopharmacy and Chemistry|November 13, 2024
Modified poly-L-lysine for use as a clearing agent in pretargeted radioimmunotherapyChiara Timperanza, Anna Gustafsson-Lutz, Tom Bäck, et al.
Comparative Medicine|August 9, 2011
Pulmonary embolization of fat and bone marrow in cynomolgus Macaques (Macaca fascicularis)Derek L Fong, Robert D Murnane, Charlotte E Hotchkiss, et al.
Expert Review of Hematology|November 21, 2014
Panobinostat: a review of trial results and future prospects in multiple myelomaEdward N Libby, Pamela S Becker, Nicholas Burwick, et al.
Transplantation and Cellular Therapy|August 27, 2023
Revisiting the Utility of Granulocyte Colony-Stimulating Factor Post-Autologous Hematopoietic Stem Cell Transplantation for Outpatient-Based TransplantationsAndrew J Portuguese, Leona Holmberg, Geoffrey R Hill, et al.
Anti-Cancer Drugs|August 4, 2015
Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulationAndrew J Cowan, Shani L Frayo, Oliver W Press, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Pretargeted radioimmunotherapy for B-cell lymphomasDamian J Green, John M Pagel, Anastasia Pantelias, et al.
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Current Hematologic Malignancy Reports|February 2, 2017
A View from the Plateau: Is There a Role for Allogeneic Stem Cell Transplantation in the Era of Highly Effective Therapies for Multiple Myeloma?Damian J Green, William I Bensinger
British Journal of Haematology|November 28, 2023
Unveiling the link between genetic alterations in gamma secretase and BCMA surface density in multiple myelomaAndrew J Cowan, Damian J Green
Cancer Research|April 22, 2017
Whither Radioimmunotherapy: To Be or Not To Be?Damian J Green, Oliver W Press
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T Cells for Multiple Myeloma: The Journey So Far-And the Road AheadAndrew J Cowan, Sherilyn A Tuazon, Andrew J Portuguese, et al.
EJNMMI Radiopharmacy and Chemistry|November 13, 2024
Modified poly-L-lysine for use as a clearing agent in pretargeted radioimmunotherapyChiara Timperanza, Anna Gustafsson-Lutz, Tom Bäck, et al.
Comparative Medicine|August 9, 2011
Pulmonary embolization of fat and bone marrow in cynomolgus Macaques (Macaca fascicularis)Derek L Fong, Robert D Murnane, Charlotte E Hotchkiss, et al.
Expert Review of Hematology|November 21, 2014
Panobinostat: a review of trial results and future prospects in multiple myelomaEdward N Libby, Pamela S Becker, Nicholas Burwick, et al.
Transplantation and Cellular Therapy|August 27, 2023
Revisiting the Utility of Granulocyte Colony-Stimulating Factor Post-Autologous Hematopoietic Stem Cell Transplantation for Outpatient-Based TransplantationsAndrew J Portuguese, Leona Holmberg, Geoffrey R Hill, et al.
Anti-Cancer Drugs|August 4, 2015
Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulationAndrew J Cowan, Shani L Frayo, Oliver W Press, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Pretargeted radioimmunotherapy for B-cell lymphomasDamian J Green, John M Pagel, Anastasia Pantelias, et al.
Pageof 10